Media.

Categories

Featured

Media Coverage
February 4th, 2019
Read

IPO ETF ‘Catch and Release’ Strategy

Academic Research
December 19th, 2019
Read

Factor Exposures for the IPOX Portfolio

Media Coverage
January 22nd, 2019
Read

Analysts See 16% Upside For The Holdings of FPX

Media Coverage

Investing In Recent IPOs With ETFs

December 5th, 2016
Read
Media Coverage

Access European IPOs With This New ETF

October 8th, 2018
Read

All media

The Market Minute: Inside Q4’s Action-Packed IPO Pipeline, Including The Year’s Biggest Expected Offering

The Market Minute: Inside Q4’s Action-Packed IPO Pipeline, Including The Year’s Biggest Expected Offering By Sophia Kunthara in Crunchbase This year has already [...]

Nov 03, 2021
Read

First Trust IPOX® Europe Equity Opportunities ETF Received 5-star in Inaugural Morningstar Rating

As of September 30, 2021, the First Trust IPOX® Europe Equity Opportunities ETF (FPXE) received 5-star Morningstar Rating. The First Trust IPOX® Europe [...]

Nov 03, 2021
Read

The definitive data-driven guide to buying the best performing IPOs – Fortune.com

    Fortune_IPOX_Feature  

Oct 25, 2021
Read

First Trust IPOX Europe Equity Opportunities ETF (FPXE) Just Turned 3

FPXE is based on the IPOX® 100 Europe Index, a market cap weighted index that measures the performance of recent European initial public [...]

Oct 25, 2021
Read

IPOX Schuster LLC teams up with Tenpath Financial for Neurodiversity Index

Planning Across The Spectrum Announces Launch of AU 79 Index, The Neurodiversity Index FARMINGTON, Conn., Oct. 25, 2021 /PRNewswire/ — Planning Across The Spectrum, in [...]

Oct 25, 2021
Read

A bunch of fitness companies have jumped into the IPO market this year. It’s [...]

A bunch of fitness companies have jumped into the IPO market this year. It’s not working out. By Ciara Linnane, MarketWatch Life Time [...]

Oct 07, 2021
Read

Discover How IPOX Can Benefit You

Services
close

  • To access Supplemental Data, please complete your details and continue.

  • In an effort to protect IPOX Schuster and the valuable intellectual property we provide on this website, please acknowledge and accept the following terms and conditions prior to accessing the IPOX Indexes information and their respective data. The identifying information requested is not used for marketing purposes.
  • By clicking the acknowledgement box, you agree to be legally bound by terms set forth herein and you represent that you are accessing the content for you own personal, non-commercial investment purposes or that you are an agent of someone doing the same. The content accessed through this portal is not for professional or commercial use, including any investment management or institutional trading purposes and may not, in any manner, be copied, reproduced, modified, stored and/or used to create any derivative works. Notwithstanding anything to the contrary, all data and information is provided by IPOX Schuster LLC (IPOX Schuster) “as is”. Neither IPOX Schuster nor any of its affiliates or third party licensors guarantee the accuracy, completeness, timeliness or availability of any content nor are any such parties liable for any damages (direct, indirect, incidental, compensatory, punitive or consequential including, without limitation, lost income or lost profits) in connection with any use of such content. You hereby acknowledge that the content is general in nature and is not tailored to the needs of any person, entity or group of persons and IPOX Schuster does not address the suitability of any security. IPOX Schuster does not act as a fiduciary or an investment advisor. IPOX Schuster does not sponsor, endorse, sell, promote or manage any investment product of fund or other vehicle that is offered by third parties and that seeks to provide an investment return based on the returns of any IPOX Index. Display of any particular index on this site does not imply that IPOX Schuster claims any investment product using the index complies with any particular regulation, including but not limited to, ESMA Guidelines on ETFs and other UCITS issues.